Amneal Pharmaceuticals, Inc. (AMRX) Social Stream
AMNEAL PHARMACEUTICALS INC (AMRX) Price Targets From Analysts
Use the tables below to see what analysts covering AMNEAL PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 7 | $8 | $5 | $6.666 | $5.99 | 11.29% |
| 2022-03-22 | 5 | $8 | $5 | $6.666 | $5.99 | 11.29% |
| 2022-05-23 | 4 | $8 | $7 | $7.333 | $5.99 | 22.42% |
| 2022-08-01 | 4 | $8 | $6 | $7 | $5.99 | 16.86% |
| 2022-08-19 | 3 | $7 | $4 | $6 | $5.99 | 0.17% |
| 2022-11-02 | 4 | $7 | $4 | $5.75 | $5.99 | -4.01% |
| 2022-11-04 | 5 | $7 | $4 | $5.25 | $5.99 | -12.35% |
| 2023-03-03 | 7 | $7 | $3 | $4.8 | $5.99 | -19.87% |
| 2023-03-10 | 7 | $5 | $3 | $4.2 | $5.99 | -29.88% |
| 2023-03-29 | 6 | $5 | $3 | $4 | $5.99 | -33.22% |
| 2023-06-14 | 5 | $4 | $3 | $3.5 | $5.99 | -41.57% |
| 2023-07-05 | 6 | $4 | $3 | $3.5 | $5.99 | -41.57% |
| 2023-07-21 | 5 | $4.001 | $3 | $3.5 | $5.99 | -41.57% |
| 2023-08-07 | 4 | $6 | $3 | $4.75 | $5.99 | -20.7% |
| 2023-10-17 | 5 | $6 | $3 | $4.75 | $5.99 | -20.7% |
| 2023-11-08 | 5 | $7 | $3 | $5.25 | $5.99 | -12.35% |
| 2023-12-07 | 5 | $7 | $3 | $5.5 | $5.99 | -8.18% |
The Trend in the Analyst Price Target
AMRX's average price target has moved down $1.5 over the prior 16 months.
Over the past 40 weeks, AMRX's average upside potential has been 65.65%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 6 | 7 | 4 | 5.00 | 1.92 | 160.42% |
| 2023-03-03 | 6 | 7 | 3 | 4.80 | 1.92 | 150% |
| 2023-05-25 | 6 | 4 | 3 | 3.60 | 2.25 | 60% |
| 2023-10-17 | 5 | 6 | 3 | 4.75 | 3.72 | 27.69% |
| 2023-11-08 | 5 | 7 | 3 | 5.25 | 4.06 | 29.31% |
AMRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 4 | 0 | 0 | 1 | 1 | 5 |
The Trend in the Broker Recommendations
Over the past 21 months, AMRX's average broker recommendation rating improved by 0.8.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how AMNEAL PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 128.23% of that group.
- In terms of how AMNEAL PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 297.52% of that group.
- AMRX has a higher number of analysts covering the stock than 668.73% of stocks in the mid market cap category.
- AMRX has a lower variance in analysts' estimates than -793.75% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, OGN, IMVT, and KOD are the three stocks most similar to AMNEAL PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for AMRX? Use POWR Ratings for clearer insight into price direction.